EPA-0654 – Lack of inhibitory control predict relapse in people willing to stop smoking

Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability...

Full description

Saved in:
Bibliographic Details
Published inEuropean psychiatry Vol. 29; p. 1
Main Authors Flaudias, V., Lopez-Castroman, J., Llorca, P.M., Schmitt, A., Perriot, J., Picot, M., Courtet, P., Quantin, X., Guillaume, S.
Format Journal Article
LanguageEnglish
Published Elsevier Masson SAS 2014
Subjects
Online AccessGet full text
ISSN0924-9338
1778-3585
DOI10.1016/S0924-9338(14)78024-1

Cover

Abstract Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability to inhibit prepotent responses) were correlated with high nicotine dependence. In this study, we focused on the link between inhibition capacity, craving, tobacco dependence and relapse. 134 smokers willing to quit smoking were consecutively included and followed prospectively. Tobacco dependence was assessed with the Fagerstorm test. We used the Hayling task to measure their inhibitory capacity and a specific questionnaire to measure tobacco craving (TCQ 12). Assessments were performed at baseline, 1, 3 and 6 months after smoking cessation. Any relapse in smoking during the follow-up was evaluated. There was an association between lower inhibition capacities and higher dependance level at baseline. Low inhibition capacities were an independent predictor of relapse at 6 months (logit R 2 = .08, F (2,134) = 10.851, p <. 004). In contrast, although level of tobacco dependence and craving predicted relapse in the short term (first month), they did not predict relapse at 6 months. These results suggest that inhibition capacities may predict smoking relapse in the long term (6 months) better than usual measures of craving. In clinical practice, an inhibition test, which is short and feasible, could be of interest to identify smokers at higher risk of relapse.
AbstractList Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability to inhibit prepotent responses) were correlated with high nicotine dependence. In this study, we focused on the link between inhibition capacity, craving, tobacco dependence and relapse. 134 smokers willing to quit smoking were consecutively included and followed prospectively. Tobacco dependence was assessed with the Fagerstorm test. We used the Hayling task to measure their inhibitory capacity and a specific questionnaire to measure tobacco craving (TCQ 12). Assessments were performed at baseline, 1, 3 and 6 months after smoking cessation. Any relapse in smoking during the follow-up was evaluated. There was an association between lower inhibition capacities and higher dependance level at baseline. Low inhibition capacities were an independent predictor of relapse at 6 months (logit R 2 = .08, F (2,134) = 10.851, p <. 004). In contrast, although level of tobacco dependence and craving predicted relapse in the short term (first month), they did not predict relapse at 6 months. These results suggest that inhibition capacities may predict smoking relapse in the long term (6 months) better than usual measures of craving. In clinical practice, an inhibition test, which is short and feasible, could be of interest to identify smokers at higher risk of relapse.
Introduction Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability to inhibit prepotent responses) were correlated with high nicotine dependence. In this study, we focused on the link between inhibition capacity, craving, tobacco dependence and relapse. Method 134 smokers willing to quit smoking were consecutively included and followed prospectively. Tobacco dependence was assessed with the Fagerstorm test. We used the Hayling task to measure their inhibitory capacity and a specific questionnaire to measure tobacco craving (TCQ 12). Assessments were performed at baseline, 1, 3 and 6 months after smoking cessation. Any relapse in smoking during the follow-up was evaluated. Results There was an association between lower inhibition capacities and higher dependance level at baseline. Low inhibition capacities were an independent predictor of relapse at 6 months (logit R2 = .08, F (2,134) = 10.851, p <. 004). In contrast, although level of tobacco dependence and craving predicted relapse in the short term (first month), they did not predict relapse at 6 months. Conclusions These results suggest that inhibition capacities may predict smoking relapse in the long term (6 months) better than usual measures of craving. In clinical practice, an inhibition test, which is short and feasible, could be of interest to identify smokers at higher risk of relapse.
Author Flaudias, V.
Lopez-Castroman, J.
Perriot, J.
Schmitt, A.
Guillaume, S.
Llorca, P.M.
Picot, M.
Quantin, X.
Courtet, P.
Author_xml – sequence: 1
  givenname: V.
  surname: Flaudias
  fullname: Flaudias, V.
  organization: EA NPsy-Sydo, Université d’Auvergne, Clermont-Ferrand, France
– sequence: 2
  givenname: J.
  surname: Lopez-Castroman
  fullname: Lopez-Castroman, J.
  organization: Pschiatric Emergency and Post Emergency, CHU Montpellier / INSERM U1061 / Fundacion Jimenez Diaz, Montpellier, France
– sequence: 3
  givenname: P.M.
  surname: Llorca
  fullname: Llorca, P.M.
  organization: Psychiatry, Université d’Auvergne, Clermont-Ferrand, France
– sequence: 4
  givenname: A.
  surname: Schmitt
  fullname: Schmitt, A.
  organization: EA NPsy-Sydo, Université d’Auvergne, Clermont-Ferrand, France
– sequence: 5
  givenname: J.
  surname: Perriot
  fullname: Perriot, J.
  organization: Dispensaire Émile Roux, Université d’Auvergne, Clermont-Ferrand, France
– sequence: 6
  givenname: M.
  surname: Picot
  fullname: Picot, M.
  organization: DIM, CHU Montpellier, Montpellier, France
– sequence: 7
  givenname: P.
  surname: Courtet
  fullname: Courtet, P.
  organization: Pschiatric Emergency and Post Emergency, CHU Montpellier / INSERM U1061, Montpellier, France
– sequence: 8
  givenname: X.
  surname: Quantin
  fullname: Quantin, X.
  organization: Respiratory Disease Department, CHU Montpellier / Laboratoire Epsylon, Montpellier, France
– sequence: 9
  givenname: S.
  surname: Guillaume
  fullname: Guillaume, S.
  organization: Psychiatric Emergency and Post Emergency, CHRU Montpellier / INSERM U1061, Montpellier, France
BookMark eNqNkM1KAzEUhYNUsK0-gpClLkZzJzOTZKFSSv2BgoK6cBXSTEbTTidDMird-Q6-oU_iTCsuBNHV5cA9H-ecAepVrjII7QM5AgLZ8S0RcRIJSvkBJIeMk1bBFuoDYzyiKU97qP_9soMGIcwJAUZI1kcPk5tRRLI0wR9v73iq9AK7Atvqyc5s4_wKa1c13pW49ia3usHelKoOpn3BtXF1afCrLUtbPeLG4dC4GoelW7R6F20Xqgxm7-sO0f355G58GU2vL67Go2mkYwCIhII8S3mmxIwKUJzonHJGaZ4VeUqJMCmLVZwyrnKuOVMcmGB8lhElREx5Toco3XC1dyF4U8ja26XyKwlEdvvI9T6yKy8hket9JLS-s43PtOFerPEyaGsq3db0Rjcyd_ZPwukPgm6HsFqVC7MyYe6efdU2lyBDLMkG0jEgWRM6wMnvgH8E-ATBkJYm
ContentType Journal Article
Copyright 2014 Elsevier Masson SAS
Elsevier Masson SAS
Copyright_xml – notice: 2014 Elsevier Masson SAS
– notice: Elsevier Masson SAS
DBID AAYXX
CITATION
DOI 10.1016/S0924-9338(14)78024-1
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList


DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1778-3585
EndPage 1
ExternalDocumentID 10_1016_S0924_9338_14_78024_1
S0924933814780241
1_s2_0_S0924933814780241
GroupedDBID ---
--K
--M
.1-
.FO
.~1
09C
09E
0R~
1B1
1P~
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8FI
8FJ
8P~
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AANRG
AAOAW
AAQXK
AASVR
AAXMD
AAXUO
AAYWO
ABBQC
ABBZL
ABFNM
ABGDZ
ABIVO
ABJNI
ABMZM
ABUWG
ABVKB
ABWVN
ABXAU
ABXDB
ABXHF
ACAJB
ACDAQ
ACDLN
ACGFS
ACHQT
ACIUM
ACQPF
ACRPL
ACVFH
ACZWT
ADAZD
ADBBV
ADCNI
ADDNB
ADEZE
ADKIL
ADMUD
ADNMO
ADOVH
ADVJH
ADVLN
AEBAK
AEKER
AENCP
AENEX
AEUPX
AEVXI
AEYHU
AFKRA
AFPKN
AFPUW
AFRHN
AFTJW
AFZFC
AGABE
AGHFR
AGJUD
AGQPQ
AGUBO
AGYEJ
AHIPN
AHRGI
AIGII
AITUG
AJPFC
AJRQY
AJUYK
AKBMS
AKMAY
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANZVX
AQJOH
ASPBG
AVWKF
AZFZN
AZQEC
BENPR
BLXMC
BLZWO
CCPQU
CCQAD
CCUQV
CFBFF
CGQII
CJCSC
CS3
DOHLZ
DU5
DWQXO
EBS
EGQIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYUFA
G-Q
GBLVA
GNUQQ
GROUPED_DOAJ
HVGLF
HZ~
IHE
IKXGN
IOO
IPYYG
J1W
LN9
M2M
M41
MO0
N9A
NZEOI
O-L
O9-
OAUVE
OH0
OK1
OU-
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PIMPY
PSYQQ
PUEGO
Q38
R2-
RCA
ROL
RPM
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSZ
UHS
UKHRP
UV1
WFFJZ
Z5R
~G-
0SF
AACTN
AFCTW
AJOXV
ALIPV
AMFUW
NCXOZ
RIG
T5K
AAEED
AAQFI
ABYKQ
AEBPU
AJBFU
EFLBG
LCYCR
LW7
AAYXX
CITATION
ID FETCH-LOGICAL-c2111-9a1d6586a9b391a80cd38733d6fd5309e572a2578ad8c87a817978b60a99238d3
IEDL.DBID .~1
ISSN 0924-9338
IngestDate Tue Jul 01 03:13:43 EDT 2025
Fri Feb 23 02:25:08 EST 2024
Sun Feb 23 10:19:45 EST 2025
Tue Aug 26 16:31:45 EDT 2025
IsPeerReviewed true
IsScholarly true
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2111-9a1d6586a9b391a80cd38733d6fd5309e572a2578ad8c87a817978b60a99238d3
PageCount 1
ParticipantIDs crossref_primary_10_1016_S0924_9338_14_78024_1
elsevier_sciencedirect_doi_10_1016_S0924_9338_14_78024_1
elsevier_clinicalkeyesjournals_1_s2_0_S0924933814780241
elsevier_clinicalkey_doi_10_1016_S0924_9338_14_78024_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014
2014-00-00
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014
PublicationDecade 2010
PublicationTitle European psychiatry
PublicationYear 2014
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
SSID ssj0017006
Score 2.0266488
Snippet Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse....
Introduction Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved...
SourceID crossref
elsevier
SourceType Index Database
Publisher
StartPage 1
SubjectTerms Internal Medicine
Psychiatry
Title EPA-0654 – Lack of inhibitory control predict relapse in people willing to stop smoking
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0924933814780241
https://www.clinicalkey.es/playcontent/1-s2.0-S0924933814780241
https://dx.doi.org/10.1016/S0924-9338(14)78024-1
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA9jB_EifuL8GDl40EO2Zknb9DjGxhAngg7mKaRNi0XcylrxJv4P_of-Jb6k3aY4GHgN76Xl8T6T93tB6IJrMyXM1UQxc1oVUk5CxhQB4wLXyDT3LVB4dOsNx_x64k5qqLfAwpi2ysr3lz7deutqpV1Js52lafveMaUDVFiU-wIijUWwc9_oeut92eZhxs_Z-0ogJoZ6heIpd7CLl5Rf2U0IXR-ffsScwS7aqZJF3C3_Zw_V4uk-2hpV1-EH6LF_1yUGt4m_Pj7xjYqe8SzB6fQpDVNzeY6rRnSczQ1PgQ1yJctjIMFl6zh-S-1QblzMsJkxgPOXmTk8P0TjQf-hNyTVWwkkghKOkkBRDcmEp4KQBVQJJ9JM-IxpL9Euc4LY9TvKmKfSIhK-EmCIvgg9RwWQ4gnNjlB9OpvGxwgzJ2HC0R3FIsoVkEaJS1mswNQjFQvRQK2FhGRWjsSQq14xEKk0IoWaQlqRStpA3kKOcoH3BA8lwWlvYvTXMcZ5ZWe5pDLvSEf-0YUGEkvOX-q0-aMn_2c9RduQT_HyhOYM1Yv5a3wOOUsRNq1SNm3F_w1NsOG-
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3bSsMwNIwJ6ot4xXnNgw_6kK1Z0jZ9HGNj6jYEN5hPIW1aLOI21olv4j_4h36JJ71MxcHA13BOWg7nfgtCF1ybLWG2JoqZbJVPOfEZUwSEC1Qj09xNB4V7facz5Dcje1RCzWIWxrRV5ro_0-mpts5Pajk1a9M4rt1bJnSACItyV4ClgRBojZtnDoCpq2-LPg-zfy4tWAI0MeDfYzzZFenhJeVX6S2ELjdQP4xOextt5d4ibmQ_tINK4XgXrffyevgeemjdNYgZ3MSf7x-4q4InPIlwPH6M_dhUz3HeiY6nM4Mzx2Z0ZZqEAIKz3nH8GqdbufF8gs2SAZw8T0z2fB8N261Bs0PyxxJIADEcJZ6iGrwJR3k-86gSVqCZcBnTTqRtZnmh7daVkU-lRSBcJUASXeE7lvLAxxOaHaDyeDIODxFmVsSEpeuKBZQrAA0im7JQgawHKhSigqoFheQ024khv5vFgKTSkBSCCpmSVNIKcgo6ymLgE1SUBK29CtFdhhgmuaAlksqkLi35hxkqSCwwf_HT6o8e_R_1HG10Br2u7F73b4_RJjhXPEvXnKDyfPYSnoIDM_fPUgb9Akwu4-A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EPA-0654+%E2%80%93+Lack+of+inhibitory+control+predict+relapse+in+people+willing+to+stop+smoking&rft.jtitle=European+psychiatry&rft.au=Flaudias%2C+V&rft.au=Lopez-Castroman%2C+J&rft.au=Llorca%2C+P.M&rft.au=Schmitt%2C+A&rft.date=2014&rft.issn=0924-9338&rft.volume=29&rft.spage=1&rft.epage=1&rft_id=info:doi/10.1016%2FS0924-9338%2814%2978024-1&rft.externalDBID=ECK1-s2.0-S0924933814780241&rft.externalDocID=1_s2_0_S0924933814780241
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09249338%2FS0924933814X7015X%2Fcov150h.gif